Advanced Accelerator Applications

Company snapshot

We are your partner of choice in Europe for precision diagnostic solutions for positron emission tomography (PET) imaging – a cornerstone of personalized nuclear medicine. Our core mission is to develop, manufacture, test, and timely supply radiopharmaceutical products for patients in need, with a primary focus on oncology, while expanding our network and expertise into other disease areas, such a

• 12 active pipeline program(s) linked via ClinicalTrials.gov.
• 25 US patent(s) indexed to this assignee profile.
• 12 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Advanced Accelerator Applications. Not investment advice.

• Peer + 0 momentum

  United Therapeutics Europe

  TA overlap score 40

• Peer + 0 momentum

  First People's Hospital

  TA overlap score 40

• Peer + 0 momentum

  INOVIO Pharmaceuticals

  TA overlap score 29.2

• Peer + 0 momentum

  Oncolytics Biotech

  TA overlap score 24.6

• Peer + 0 momentum

  Peking University Biologics

  TA overlap score 23

Recent activity

Latest pipeline, patent, and corporate events for Advanced Accelerator Applications.

1. Jun 8, 2026 Clinical update

   ABX-CT-302EU/EAGLE-i — Phase 3

2. Jun 8, 2026 Clinical update

   ODYSSEY — Phase 1

3. Jun 8, 2026 Clinical update

   CAAA601A32201 — Phase 2

4. Jun 8, 2026 Clinical update

   CAAA601A22301 — Phase 3

5. Jun 8, 2026 Clinical update

   APISLIT-DD-D-2025-01 — Phase 2

View all clinical trial activity →

• What is Advanced Accelerator Applications?

  Advanced Accelerator Applications is a pharma organization headquartered in RUEIL-MALMAISON, FR. Primary therapeutic focus areas include Allergies, Early Parkinson Disease, Breast Cancer, Recurrent or Metastatic Breast Cancer, Prostate Cancer. NovaPharmaNews links 12 clinical pro

• Is Advanced Accelerator Applications publicly traded?

  Advanced Accelerator Applications appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Advanced Accelerator Applications develop or market?

  We link 25 drug profile(s) where Advanced Accelerator Applications is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/advanced-accelerator-applications#company-drugs.

• What are the latest developments for Advanced Accelerator Applications?

  In the last 12 months our linked public records show 12 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Advanced Accelerator Applications focus on?

  Advanced Accelerator Applications focuses on Allergies, Early Parkinson Disease, Breast Cancer based on our analysis of their pipeline programs and drug development activities.